Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis
Ye-chong Liu1, Weng-sheng Tsai, Tom Chau
1Division of Nephrology, Department of Medicine, Zuoying Armed Forces Hospital, Kaoshiung, Taipei, Taiwan, ROC.
The American Journal of the Medical Sciences
|May 29, 2004
Summary
Thyrotoxic periodic paralysis (TPP) can cause acute respiratory failure and muscle weakness. Prompt recognition and management are crucial to prevent severe complications and ensure patient recovery.
Area of Science:
- Endocrinology
- Neurology
- Critical Care Medicine
Background:
- Thyrotoxic periodic paralysis (TPP) is a rare condition characterized by hypokalemia due to intracellular potassium shifts.
- Acute hypercapnic respiratory failure is a severe complication typically associated with profound hypokalemia from total body potassium deficits.
Observation:
- A 29-year-old male presented with sudden paralysis and acute respiratory insufficiency.
- Intravenous potassium chloride (KCl) administration initially improved muscle strength but led to rebound hyperkalemia.
Findings:
- The patient required mechanical ventilation due to respiratory failure.
- Diagnosis of TPP was confirmed by elevated free thyroxine and suppressed TSH levels.
- Rebound hyperkalemia occurred despite discontinuation of KCl, indicating complex potassium dynamics.
Implications:
- TPP should be considered in patients presenting with acute muscle weakness and respiratory failure.
- Early diagnosis and appropriate management of TPP are essential to avoid delayed treatment and adverse outcomes.
- This case highlights the unusual presentation of respiratory failure in TPP and the challenges in managing associated electrolyte disturbances.
More Related Videos
Related Concept Videos
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...